Laurion Capital Management LP Repligen Corp Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $1.46 Million - $1.88 Million	-11,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $1.12 Million - $1.67 Million	11,900 New	11,900 $1.47 Million
Q4 2019 Feb 13, 2020	SELL	$73.84 - $93.08 $1.73 Million - $2.18 Million	-23,400 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$76.65 - $95.51 $130,994 - $163,226	1,709 Added 7.88%	23,400 $1.8 Million
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $1.18 Million - $1.86 Million	21,691 New	21,691 $1.86 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $4.26 Million - $6.09 Million	-88,359 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $4.14 Million - $5.21 Million	88,359 New	88,359 $4.9 Million

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.82B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.